SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 254 filers reported holding SAGE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $117,246 | -54.4% | 10,796 | -21.3% | 0.00% | -100.0% |
Q1 2024 | $256,982 | -5.8% | 13,713 | +9.0% | 0.00% | 0.0% |
Q4 2023 | $272,673 | +22.9% | 12,583 | +16.7% | 0.00% | 0.0% |
Q3 2023 | $221,894 | -56.1% | 10,782 | +0.4% | 0.00% | 0.0% |
Q2 2023 | $505,135 | +17.2% | 10,743 | +4.6% | 0.00% | 0.0% |
Q1 2023 | $430,971 | -2.8% | 10,271 | -11.6% | 0.00% | -50.0% |
Q4 2022 | $443,339 | +5.6% | 11,624 | +8.2% | 0.00% | 0.0% |
Q3 2022 | $420,000 | +24.3% | 10,742 | +2.8% | 0.00% | +100.0% |
Q2 2022 | $338,000 | +67.3% | 10,450 | +71.0% | 0.00% | – |
Q1 2022 | $202,000 | -42.8% | 6,111 | -26.3% | 0.00% | -100.0% |
Q4 2021 | $353,000 | -36.6% | 8,295 | -34.0% | 0.00% | -50.0% |
Q3 2021 | $557,000 | -6.7% | 12,565 | +19.6% | 0.00% | 0.0% |
Q2 2021 | $597,000 | -1.3% | 10,507 | +30.1% | 0.00% | 0.0% |
Q1 2021 | $605,000 | -12.9% | 8,078 | +0.6% | 0.00% | -33.3% |
Q4 2020 | $695,000 | +36.0% | 8,031 | -3.9% | 0.00% | +50.0% |
Q3 2020 | $511,000 | +34.5% | 8,359 | -8.5% | 0.00% | 0.0% |
Q2 2020 | $380,000 | +63.8% | 9,134 | +13.0% | 0.00% | 0.0% |
Q1 2020 | $232,000 | -74.2% | 8,083 | -35.0% | 0.00% | -50.0% |
Q4 2019 | $898,000 | -57.9% | 12,444 | -18.1% | 0.00% | -66.7% |
Q3 2019 | $2,132,000 | -28.0% | 15,198 | -6.0% | 0.01% | -33.3% |
Q2 2019 | $2,961,000 | -3.6% | 16,170 | -16.3% | 0.02% | 0.0% |
Q1 2019 | $3,073,000 | +85.8% | 19,321 | +11.9% | 0.02% | +50.0% |
Q4 2018 | $1,654,000 | -43.4% | 17,272 | -16.5% | 0.01% | -40.0% |
Q3 2018 | $2,921,000 | -4.5% | 20,679 | +5.8% | 0.02% | -4.8% |
Q2 2018 | $3,060,000 | -28.4% | 19,548 | -26.4% | 0.02% | -25.0% |
Q1 2018 | $4,276,000 | -7.4% | 26,549 | -5.3% | 0.03% | -12.5% |
Q4 2017 | $4,618,000 | +215.9% | 28,036 | +19.5% | 0.03% | +146.2% |
Q3 2017 | $1,462,000 | -17.4% | 23,465 | +5.6% | 0.01% | -27.8% |
Q2 2017 | $1,770,000 | +6.6% | 22,222 | -4.9% | 0.02% | +5.9% |
Q1 2017 | $1,660,000 | +10.6% | 23,362 | -20.5% | 0.02% | 0.0% |
Q4 2016 | $1,501,000 | +39.9% | 29,396 | +26.2% | 0.02% | +13.3% |
Q3 2016 | $1,073,000 | +31.3% | 23,291 | -14.1% | 0.02% | +36.4% |
Q2 2016 | $817,000 | -0.5% | 27,110 | +5.9% | 0.01% | 0.0% |
Q1 2016 | $821,000 | -44.1% | 25,610 | +1.6% | 0.01% | -38.9% |
Q4 2015 | $1,470,000 | +49.1% | 25,219 | +8.2% | 0.02% | +28.6% |
Q3 2015 | $986,000 | -44.6% | 23,300 | -4.5% | 0.01% | -44.0% |
Q2 2015 | $1,781,000 | +62.9% | 24,404 | +12.2% | 0.02% | +92.3% |
Q1 2015 | $1,093,000 | +63.1% | 21,756 | +18.8% | 0.01% | +62.5% |
Q4 2014 | $670,000 | – | 18,312 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Rock Ventures, LLC | 9,773,073 | $490,901,000 | 52.36% |
Ghost Tree Capital, LLC | 240,000 | $12,056,000 | 2.17% |
EcoR1 Capital, LLC | 112,455 | $5,649,000 | 1.88% |
New Leaf Venture Partners, L.L.C. | 43,770 | $2,199,000 | 1.49% |
AlpInvest Partners B.V. | 12,195 | $613,000 | 1.15% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 595,443 | $29,909,000 | 0.97% |
APEX CAPITAL, LLC | 190,000 | $9,544,000 | 0.69% |
OAK RIDGE INVESTMENTS LLC | 385,770 | $19,377,000 | 0.43% |
Lombard Odier Asset Management (USA) Corp | 92,089 | $4,626,000 | 0.37% |
SPHERA FUNDS MANAGEMENT LTD. | 65,724 | $3,301,000 | 0.34% |